Database Commons
Database Commons

a catalog of worldwide biological databases

Database Profile

Antimicrobial Combinations

General information

URL: http://sing.ei.uvigo.es/antimicrobialCombination/
Full name: Antimicrobial Combination Networks
Description: Our database aims to bridge the gap between agent repositories and studies documenting the effect of antimicrobial combination therapies. Most notably, our primary aim is to compile data on the combination of antimicrobial agents, namely natural products such as AMP. To meet this purpose, we have developed a data curation workflow that combines text mining, manual expert curation and graph analysis and supports the reconstruction of AMP-Drug combinations. The initial release of the database focused on antimicrobial combinations that have been experimentally tested againstPseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, Listeria monocytogenes and Candida albicans, which are prominent pathogenic organisms and are well-known for their wide and growing resistance to conventional antimicrobials. Besides maintaining these data collections, we are extending literature screening to a wider collection of organisms.
Year founded: 2016
Last update: 2017-06-01
Version:
Accessibility:
Accessible
Country/Region: Spain

Contact information

University/Institution: University of Vigo
Address: ESEI - Department of Computer Science
City: Ourense
Province/State: Ourense
Country/Region: Spain
Contact name (PI/Team): Anália Lourenço
Contact email (PI/Helpdesk): analia@uvigo.es

Publications

Ranking

All databases:
6121/6278 (2.517%)
Health and medicine:
1462/1501 (2.665%)
Literature:
533/540 (1.481%)
6121
Total Rank
1
Citations
0.125
z-index

Community reviews

Not Rated
Data quality & quantity:
Content organization & presentation
System accessibility & reliability:

Word cloud

Created with Highcharts 10.0.0antimicrobialAntimicrobial Combinationscombinationscientificliteraturecombinationsdatabaseagentssemi-automatedcurationworkflowgrowingresistanceexperimentalorganismstestedConstructionpeptide-drugnetworksbasedConsiderableresearcheffortsinvesteddevelopmentnoveltherapieseffectivenumbermulti-drugresistantpathogensNotablydifferentincreasinglyexploredmeansexploitimproveindividualagentactionsminimizingmicroorganismAlthoughseveraldatabasesprimarysourceinformationtestingworkpresentssupportsminingenablesreconstructionrecentlydocumentedCurrentlycontainsdataexperimentallyPseudomonasaeruginosaStaphylococcusaureusEscherichiacoliListeriamonocytogenesCandidaalbicansprominentpathogenicwell-knownwideconventionalantimicrobialsResearchersableexploreresultssingleorganismacrossLikewiseresearchersmaylookindirectnetworkassociationsidentifynewpotentialavailablewithout

Related Databases

Cited by

Record metadata

Created on: 2017-03-29
Curated by:
[2018-11-28]
Dong Zou [2018-03-09]
Lina Ma [2017-06-01]
Shixiang Sun [2017-03-29]